Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The Diagnostic Imaging Devices market in Lebanon has been experiencing steady growth in recent years. Customer preferences in the Diagnostic Imaging Devices market in Lebanon are driven by a combination of factors. Firstly, customers in Lebanon prefer advanced imaging technologies that offer high-resolution images and accurate diagnostic capabilities. They value devices that can provide detailed and precise information for effective treatment planning and monitoring. Additionally, customers in Lebanon also prioritize compact and portable imaging devices that offer convenience and flexibility in different healthcare settings. Trends in the Diagnostic Imaging Devices market in Lebanon reflect global trends in the industry. One key trend is the increasing demand for digital imaging technologies. Digital imaging devices offer numerous advantages over traditional film-based systems, including faster image acquisition, enhanced image quality, and the ability to easily store and share images electronically. This trend is driven by the need for efficient and streamlined workflows in healthcare facilities. Another trend is the growing adoption of artificial intelligence (AI) in diagnostic imaging devices. AI algorithms can analyze medical images and assist healthcare professionals in making accurate diagnoses. This trend is driven by the desire to improve diagnostic accuracy and efficiency. Local special circumstances in Lebanon impact the Diagnostic Imaging Devices market. One such circumstance is the country's healthcare infrastructure. Lebanon has a well-developed healthcare system with a high number of hospitals and medical centers. This provides a strong demand for diagnostic imaging devices. Additionally, Lebanon has a high prevalence of chronic diseases, such as cardiovascular diseases and cancer, which require regular diagnostic imaging. This further drives the demand for imaging devices in the country. Underlying macroeconomic factors also contribute to the development of the Diagnostic Imaging Devices market in Lebanon. The country has a relatively stable economy and a growing middle class, which has increased the affordability of healthcare services. This has led to an increase in healthcare spending, including investments in diagnostic imaging devices. Furthermore, the government of Lebanon has been actively promoting healthcare as a priority sector, which has attracted investments and contributed to the growth of the market. In conclusion, the Diagnostic Imaging Devices market in Lebanon is developing due to customer preferences for advanced imaging technologies, trends in digital imaging and AI, local special circumstances such as the healthcare infrastructure and disease prevalence, and underlying macroeconomic factors such as a stable economy and government support for the healthcare sector.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights